Henry Schein CEO Stanley M. Bergman to Retire After 45 Years
Stanley M. Bergman will retire as CEO of Henry Schein at the end of 2025, concluding a 45-year tenure that included more than 35 years
Stanley M. Bergman will retire as CEO of Henry Schein at the end of 2025, concluding a 45-year tenure that included more than 35 years
Edwards Lifesciences has recalled over 61,000 units of its OptiSite Arterial Cannula and FEM-Flex II Femoral Arterial Cannula due to a potential safety hazard, according
Route 92 Medical reported positive outcomes from a retrospective multicenter study of its FDA-cleared HiPoint 88 reperfusion system for acute ischemic stroke. The HiPoint 88
The FDA has approved Bayer’s finerenone (Kerendia), a non-steroidal mineralocorticoid receptor antagonist (MRA), for patients with heart failure and left ventricular ejection fraction (LVEF) ≥40%.
Siemens Healthineers’ Varian announced the CE marking and European launch of its IntelliBlate microwave ablation system for image-guided cancer therapy. The system received FDA clearance
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
